Date: 11/8/2006
Length: 00:15:40
Size: 7.17MB
Thought Leader: Richard W. Pascoe, VP and Chief Commercial Officer, Ariad Pharmaceuticals Inc.
Transforming a company from an R&D organization into a commercialization entity can be a daunting undertaking. You'll learn about the building blocks of a commercial platform, strategic planning, inevitable obstacles, and best practices that can be used on the journey.
Play Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Tuesday, November 21, 2006
Tuesday, November 07, 2006
New Marketing Paradigm for Patient-Physician Communications
Date: 10/27/2006
Length: 00:17:20
Size: 7.93MB
Thought Leaders: Jeanne Zucker, VP, Strategic Business Development, and Paul LeVine, VP, Analytic Services, InfoMedics Inc.
Pharmaceutical companies must radically change the way they market to patients and physicians. By creating an environment of collaboration, including more communications between patients and physicians, improved treatment outcomes are possible, while maintaining compliance.
Play Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:17:20
Size: 7.93MB
Thought Leaders: Jeanne Zucker, VP, Strategic Business Development, and Paul LeVine, VP, Analytic Services, InfoMedics Inc.
Pharmaceutical companies must radically change the way they market to patients and physicians. By creating an environment of collaboration, including more communications between patients and physicians, improved treatment outcomes are possible, while maintaining compliance.
Play Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Structuring a Successful Global Marketing Campaign
Date: 10/13/2006
Length: 00:17:52
Size: 8.18MB
Thought Leader: Phil Deschamps, President and CEO, GSW Worldwide
Is a global campaign the right move for your brand? Is your organization set up to successfully launch a global initiative? This Podcast illuminates the necessary components to take a brand global and at the same time avoid some of the common pitfalls that can potentially damage a global campaign.
Play Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:17:52
Size: 8.18MB
Thought Leader: Phil Deschamps, President and CEO, GSW Worldwide
Is a global campaign the right move for your brand? Is your organization set up to successfully launch a global initiative? This Podcast illuminates the necessary components to take a brand global and at the same time avoid some of the common pitfalls that can potentially damage a global campaign.
Play Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Wednesday, October 18, 2006
Electronic Submissions and eCTD Challenges
Date: 10/11/2006
Length: 00:15:08
Size: 6.93MB
Thought Leader: John Lawrie, VP, Process Solutions — Octagon Research Solutions Inc.
Submitting drug applications electronically has many advantages, and the industry is progressively adopting this practice as its standard. Learn how to navigate the complex waters of esubs and developing eCTD capabilities.
Play Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:15:08
Size: 6.93MB
Thought Leader: John Lawrie, VP, Process Solutions — Octagon Research Solutions Inc.
Submitting drug applications electronically has many advantages, and the industry is progressively adopting this practice as its standard. Learn how to navigate the complex waters of esubs and developing eCTD capabilities.
Play Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Monday, October 09, 2006
Marketing to Managed Care
Date: 10/3/2006
Length: 00:13:46
Size: 6.4MB
Thought Leader: Mark Zitter, Founder and CEO, The Zitter Group
While DTC and physician marketing get all the attention, managed care often gets left behind. Learn why it's so important for manufacturers to market to payers and understand the function of the P&T Committee. Hear about the strategies and tactics that deliver the most impact for your brand.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:13:46
Size: 6.4MB
Thought Leader: Mark Zitter, Founder and CEO, The Zitter Group
While DTC and physician marketing get all the attention, managed care often gets left behind. Learn why it's so important for manufacturers to market to payers and understand the function of the P&T Committee. Hear about the strategies and tactics that deliver the most impact for your brand.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
The Silent Exam Room
Date: 9/21/2006
Length: 00:28:44
Size: 13.1MB
Thought Leaders:
Stanley Wulf, M.D., VP, Chief Medical Officer, InfoMedics Inc.
Paul LeVine, VP, Analytic Services, InfoMedics Inc.
Do physicians and patients ever really talk anymore? In these go-go times, this relationship has broken down, and patient care suffers. Find out how to improve physician-patient communications and what that means to physicians, patients, and pharmaceutical companies.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:28:44
Size: 13.1MB
Thought Leaders:
Stanley Wulf, M.D., VP, Chief Medical Officer, InfoMedics Inc.
Paul LeVine, VP, Analytic Services, InfoMedics Inc.
Do physicians and patients ever really talk anymore? In these go-go times, this relationship has broken down, and patient care suffers. Find out how to improve physician-patient communications and what that means to physicians, patients, and pharmaceutical companies.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Friday, September 15, 2006
Overcoming Marketing Challenges
Date: 9/11/2006
Length: 00:12:06
Size: 5.54MB
Thought Leader: Lauren Coyle, Senior Product Manager, Otsuka America Pharmaceutical Inc.
Pharmaceutical marketing has never been more complex. In this episode, we tackle six important issues from the product manager's perspective.
Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:12:06
Size: 5.54MB
Thought Leader: Lauren Coyle, Senior Product Manager, Otsuka America Pharmaceutical Inc.
Pharmaceutical marketing has never been more complex. In this episode, we tackle six important issues from the product manager's perspective.
Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Patient Safety and IRB Accreditation
Date: 8/25/2006
Length: 00:11:55
Size: 5.45MB
Thought Leader: Lynn A. Meyer, CIP, CIM, President, IntegReview Ethical Review Board
Does an accredited Institutional Review Board (IRB) improve patient safety? This podcast covers the pros and cons of accreditation and some of the issues involved in patient safety and trial efficiency during clinical trials on humans.
Full podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:11:55
Size: 5.45MB
Thought Leader: Lynn A. Meyer, CIP, CIM, President, IntegReview Ethical Review Board
Does an accredited Institutional Review Board (IRB) improve patient safety? This podcast covers the pros and cons of accreditation and some of the issues involved in patient safety and trial efficiency during clinical trials on humans.
Full podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Wednesday, July 19, 2006
Novartis' Forward-thinking Training Strategy
Date: 07/12/2006
Length: 00:20:04
Size: 9.18MB
Thought Leader: John Talanca Jr., Head, Learning Technologies — Novartis Pharmaceuticals Corporation
At Novartis, learning is a respected part of the workday for sales reps. Learn how to make it a reality in your company. E-learning and other important technologies are also discussed. Hear about Novartis' training outsourcing strategy, and discover some emerging trends in training.
Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:20:04
Size: 9.18MB
Thought Leader: John Talanca Jr., Head, Learning Technologies — Novartis Pharmaceuticals Corporation
At Novartis, learning is a respected part of the workday for sales reps. Learn how to make it a reality in your company. E-learning and other important technologies are also discussed. Hear about Novartis' training outsourcing strategy, and discover some emerging trends in training.
Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Pharma's Contribution to Innovations in Healthcare
Date: 7/13/2006
Length: 00:18:55
Size: 8.65MB
Thought Leader: Leslie Williams, Founder, President and CEO — Ventaira Pharmaceuticals
Ventaira CEO Leslie Williams provides keen insights into several pharma-related topics, including promising areas in medicine, challenges in clinical development, innovations in inhalation technologies, a look at the pharma industry in 10 years, maximizing partnerships with pharma & biotech companies, the pros and cons of being privately held, and how pharma fits into the healthcare spectrum.
Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:18:55
Size: 8.65MB
Thought Leader: Leslie Williams, Founder, President and CEO — Ventaira Pharmaceuticals
Ventaira CEO Leslie Williams provides keen insights into several pharma-related topics, including promising areas in medicine, challenges in clinical development, innovations in inhalation technologies, a look at the pharma industry in 10 years, maximizing partnerships with pharma & biotech companies, the pros and cons of being privately held, and how pharma fits into the healthcare spectrum.
Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Optimizing Pharmaceutical Marketing
Date: 7/11/2006
Length: 00:13:11
Size: 6.03MB
Thought Leader: David Zaritsky, Managing Director, Pharmaceutical Markets, Harte-Hanks Inc.
Learn more about the changing landscape of pharmaceutical marketing. This episode features a compelling discussion on maximizing total prescriptions through customer optimization and non-manpowered selling.
Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:13:11
Size: 6.03MB
Thought Leader: David Zaritsky, Managing Director, Pharmaceutical Markets, Harte-Hanks Inc.
Learn more about the changing landscape of pharmaceutical marketing. This episode features a compelling discussion on maximizing total prescriptions through customer optimization and non-manpowered selling.
Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Innovative Technologies in Clinical Research
Date: 7/10/2006
Length: 00:35:25
Size: 16.2MB
Thought Leader: Anthony J. Costello, Founder and VP, Product Development and Data, Nextrials Inc.
Discover the newest technologies in clinical research, including a discussion on the ROI of technology implementations and industry adoption rates. Also covered are Electronic Data Collection, electronic health records, industry standards, and regulatory guidances.
Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:35:25
Size: 16.2MB
Thought Leader: Anthony J. Costello, Founder and VP, Product Development and Data, Nextrials Inc.
Discover the newest technologies in clinical research, including a discussion on the ROI of technology implementations and industry adoption rates. Also covered are Electronic Data Collection, electronic health records, industry standards, and regulatory guidances.
Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Oncolytics Biotech Provides Insider Insights into Clinical Research
Date: 7/11/2006
Length: 00:15:48
Size: 7.24MB
Thought Leader: Brad Thompson, Ph.D., President and CEO — Oncolytics Biotech Inc.
The CEO of Oncolytics Biotech speaks on a variety of topics, including challenges in clinical research and patient recruitment in oncological studies.
Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:15:48
Size: 7.24MB
Thought Leader: Brad Thompson, Ph.D., President and CEO — Oncolytics Biotech Inc.
The CEO of Oncolytics Biotech speaks on a variety of topics, including challenges in clinical research and patient recruitment in oncological studies.
Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Innovations in Clinical Development for Biotechnology
Date: 7/10/2006
Length: 00:19:38
Size: 8.99MB
Thought Leader: Russell H. Ellison, M.D., M.Sc., VP, Clinical Development — Fibrogen Inc.
Learn about obstacles in the development of clinical programs, drug development models, hot areas in scientific development, emerging trends in biotechnology, and an expert's view of the future in the industry...
Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:19:38
Size: 8.99MB
Thought Leader: Russell H. Ellison, M.D., M.Sc., VP, Clinical Development — Fibrogen Inc.
Learn about obstacles in the development of clinical programs, drug development models, hot areas in scientific development, emerging trends in biotechnology, and an expert's view of the future in the industry...
Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Tuesday, June 13, 2006
Roche Pharma Partnering: Beyond the Deal
Date: 04/11/06
Length: 00:17:02
Size: 7.9MB
Thought Leader: Dr. Peter Hug, Executive VP, Pharma Partnering — F. Hoffman-La Roche Ltd.
Find out what pharmaceutical giant Roche looks for in partnering opportunities, as well as views on personalized medicine and venture capitalists...
Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:17:02
Size: 7.9MB
Thought Leader: Dr. Peter Hug, Executive VP, Pharma Partnering — F. Hoffman-La Roche Ltd.
Find out what pharmaceutical giant Roche looks for in partnering opportunities, as well as views on personalized medicine and venture capitalists...
Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
How Consumer Web Traffic May Impact Revenue for Top Selling Drugs
Date: 03/27/06
Length: 00:18:15
Size: 8.5MB
Thought Leader: Daniel Limbach, Managing Editor — PharmaVOICE VIEW magazine
Do the top selling drugs have the highest traffic Websites? Is there a connection? We study this premise using recent traffic data and drug sales figures. You might be surprised what we discovered...
Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:18:15
Size: 8.5MB
Thought Leader: Daniel Limbach, Managing Editor — PharmaVOICE VIEW magazine
Do the top selling drugs have the highest traffic Websites? Is there a connection? We study this premise using recent traffic data and drug sales figures. You might be surprised what we discovered...
Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Evolution of a Biopharmaceutical Company: Nektar Therapeutics
Date: 04/11/06
Length: 00:11:48
Size: 5.5MB
Thought Leader: Hoyoung Huh, M.D. Ph.D., Senior VP, Business Development — Nektar Therapeutics
Nektar has crossed the chasm from a drug-delivery-technology company to a product-development company. Dr. Huh describes how they made the transition, and what to look for from them in the future.
Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:11:48
Size: 5.5MB
Thought Leader: Hoyoung Huh, M.D. Ph.D., Senior VP, Business Development — Nektar Therapeutics
Nektar has crossed the chasm from a drug-delivery-technology company to a product-development company. Dr. Huh describes how they made the transition, and what to look for from them in the future.
Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Thursday, June 08, 2006
Ohio - An Emerging Biotech Region
Date: 04/10/06
Length: 00:05:46
Size: 2.7MB
Thought Leader: Bob Taft, Governor — State of Ohio
When listing the top biotech regions in the U.S., Ohio is not always included with renown biotech states such as California, Massachusetts, or even Wisconsin. Governor Taft explains how Ohio is becoming a top biotech region...
Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:05:46
Size: 2.7MB
Thought Leader: Bob Taft, Governor — State of Ohio
When listing the top biotech regions in the U.S., Ohio is not always included with renown biotech states such as California, Massachusetts, or even Wisconsin. Governor Taft explains how Ohio is becoming a top biotech region...
Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Wednesday, May 31, 2006
Billionaire Lifting NC to Top of Biotechnology Industry
Date: 04/10/06
Length: 00:23:57
Size: 11MB
Thought Leader: David Murdock, Owner — Castle & Cooke Inc. and Dole Food Company Inc.
Many billionaires leave their legacy through endowments and charitable donations. David Murdock is taking a hands-on approach, and building a state-of-the-art biotech campus with over $1 billion of his own money. Mr. Murdock shares his vision.
Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:23:57
Size: 11MB
Thought Leader: David Murdock, Owner — Castle & Cooke Inc. and Dole Food Company Inc.
Many billionaires leave their legacy through endowments and charitable donations. David Murdock is taking a hands-on approach, and building a state-of-the-art biotech campus with over $1 billion of his own money. Mr. Murdock shares his vision.
Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Innovations in Drug Packaging and Formulations
Date: 04/06/06
Length: 00:18:49
Size: 8.8MB
Thought Leader: Joel Tune, General Manager — Baxter BioPharma Solutions
Baxter Biopharma Solutions knows outsourcing — especially when it comes to syringes and vials. Now they are into nanotechnology and other new technologies that extend the life of a compound. Find out more about this division of Baxter Healthcare.
Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:18:49
Size: 8.8MB
Thought Leader: Joel Tune, General Manager — Baxter BioPharma Solutions
Baxter Biopharma Solutions knows outsourcing — especially when it comes to syringes and vials. Now they are into nanotechnology and other new technologies that extend the life of a compound. Find out more about this division of Baxter Healthcare.
Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Personalizing Patient Compliance
Date: 04/17/06
Length: 00:34:45
Size: 16.2MB
Thought Leader: Kevin Wildenhaus Ph.D., Director of Behavioral Science — HealthMedia Inc.
In this compelling podcast, Kevin Wildenhaus outlines his "FIRE and ICE" program. Find out what it stands for and then apply it to your work.
Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:34:45
Size: 16.2MB
Thought Leader: Kevin Wildenhaus Ph.D., Director of Behavioral Science — HealthMedia Inc.
In this compelling podcast, Kevin Wildenhaus outlines his "FIRE and ICE" program. Find out what it stands for and then apply it to your work.
Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
One-Stop Shopping for the Life Sciences
Date of recording: 04/09/06
Length: 00:13:27
Size: 6.3MB
Featured Thought Leader: Greg Lucier, CEO, Invitrogen
Is there a one-stop shop for biotechnology? Find out how Invitrogen's Web-based initiatives and outsourcing services contributed to their rapid growth and make them a company to watch in 2006. Recorded at the BIO 2006 conference.
Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:13:27
Size: 6.3MB
Featured Thought Leader: Greg Lucier, CEO, Invitrogen
Is there a one-stop shop for biotechnology? Find out how Invitrogen's Web-based initiatives and outsourcing services contributed to their rapid growth and make them a company to watch in 2006. Recorded at the BIO 2006 conference.
Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Subscribe to:
Posts (Atom)